热景生物(688068.SH):参股公司尧景基因拟通过新设立有限合伙企业对尧景基因进行增资并实施股权激励

Core Viewpoint - The company is optimizing its equity structure and enhancing long-term incentive mechanisms to attract and retain talent, thereby promoting stable long-term business development through a capital increase and equity incentive plan for its subsidiary, Yaojing Gene [1] Group 1: Capital Increase and Equity Incentive - The company plans to increase capital in Yaojing Gene through a newly established limited partnership (employee stock ownership platform) with a total investment amount of 16 million yuan at a price of 1.6 yuan per registered capital [1] - The company will waive its preferential subscription rights for this capital increase, which constitutes a related party transaction but does not qualify as a major asset restructuring under the relevant regulations [1] Group 2: Management Involvement - The company's controlling shareholder, actual controller, chairman, and general manager, Lin Changqing, will serve as the chairman of Yaojing Gene, while the board secretary and deputy general manager, Shi Yongzhan, will act as the financial officer of Yaojing Gene [1] - Lin Changqing will also be the general partner of the employee stock ownership platform being established by Yaojing Gene [1]